Startup Nilo Launches With $101M for Autoimmune Drugs That Target ‘Brain-Body Circuits’ Read More October 8, 2025
Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder IPF Read More October 7, 2025